Oric Pharmaceuticals

ORIC Pharmaceuticals is an American pharmaceutical company. It discovers and develops novel therapies for the treatment of cancer diseases. ORIC Pharmaceuticals serves customers in the State of California.
Oric Pharmaceuticals stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Oric Pharmaceuticals balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Oric Pharmaceuticals cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Oric Pharmaceuticals multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Oric Pharmaceuticals profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Oric Pharmaceuticals assets
Oric Pharmaceuticals cash flows

Oric Pharmaceuticals dividend policy

The company doesn't provide dividend.

Oric Pharmaceuticals shares

TickerNameTypeNominal valueISINPrice
ORIC:USOric PharmaceuticalsCommon share-US68622P1093$10.26
Oric Pharmaceuticals news
10.05.2022
Oric Pharmaceuticals' GAAP loss for 3 months of 2022 was $23.159 million, up 40.3% from $16.509 million in the previous year.
Source: {source} pictogram investors.oricpharma.com
Pictogram next
22.03.2022
Oric Pharmaceuticals' GAAP loss for 2021 was $78.715 million, up 6.8% from $73.703 million the previous year.
Source: {source} pictogram investors.oricpharma.com
Pictogram next
09.11.2021
Oric Pharmaceuticals' GAAP loss for 9M 2021 was $55.944 million, up 23.1% from $45.444 million in the prior year.
Source: {source} pictogram investors.oricpharma.com
Pictogram next
11.08.2021
Oric Pharmaceuticals' GAAP loss for 6M 2021 was $37.518 million, up 88.6% from $19.896 million in the previous year.
Source: {source} pictogram investors.oricpharma.com
Pictogram next
All Oric Pharmaceuticals news
General information
Company nameOric Pharmaceuticals
SectorHealth Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Mailing address240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Websiteinvestors.oricpharma.com
Information disclosurewww.sec.gov